Thomas Andrew Crockett - Net Worth and Insider Trading

Thomas Andrew Crockett Net Worth

The estimated net worth of Thomas Andrew Crockett is at least $3 Million dollars as of 2025-05-22. Thomas Andrew Crockett is the CEO of KalVista Pharmaceuticals Inc and owns about 211,203 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $3 Million. Details can be seen in Thomas Andrew Crockett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Andrew Crockett has not made any transactions after 2024-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Thomas Andrew Crockett

To

Thomas Andrew Crockett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Andrew Crockett owns 1 companies in total, including KalVista Pharmaceuticals Inc (KALV) .

Click here to see the complete history of Thomas Andrew Crockett’s form 4 insider trades.

Insider Ownership Summary of Thomas Andrew Crockett

Ticker Company Transaction Date Type of Owner
KALV KalVista Pharmaceuticals Inc 2024-02-20 director & President and CEO

Thomas Andrew Crockett Latest Holdings Summary

Thomas Andrew Crockett currently owns a total of 1 stock. Thomas Andrew Crockett owns 211,203 shares of KalVista Pharmaceuticals Inc (KALV) as of February 20, 2024, with a value of $3 Million.

Latest Holdings of Thomas Andrew Crockett

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KALV KalVista Pharmaceuticals Inc 2024-02-20 211,203 11.88 2,508,036

Holding Weightings of Thomas Andrew Crockett


Thomas Andrew Crockett Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Andrew Crockett has made a total of 20 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 24,888 shares on February 20, 2024, which brought Thomas Andrew Crockett around $351,170.

Insider Trading History of Thomas Andrew Crockett

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Andrew Crockett Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Andrew Crockett Ownership Network

Ownership Network List of Thomas Andrew Crockett

No Data

Ownership Network Relation of Thomas Andrew Crockett

Insider Network Chart


Thomas Andrew Crockett Owned Company Details

What does KalVista Pharmaceuticals Inc do?

Who are the key executives at KalVista Pharmaceuticals Inc?

Thomas Andrew Crockett is the director & President and CEO of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Medical Officer Paul K. Audhya , CFO and Secretary Benjamin L Palleiko , and Chief Development Officer Christopher Yea .

KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary

Over the past 18 months, Thomas Andrew Crockett made 4 insider transaction in KalVista Pharmaceuticals Inc (KALV) with a net sale of 123,244. Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,612,229 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 152,256 shares made by Benjamin L Palleiko , and a net sale of 88,841 shares made by Christopher Yea .

In summary, during the past 3 months, insiders sold 20,165 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 25,000 shares, with a net purchase of 4,835 shares. During the past 18 months, 525,025 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,612,229 shares were bought by its insiders, resulting in a net purchase of 1,087,204 shares.

KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

KalVista Pharmaceuticals Inc Insider Transactions

No Available Data

Thomas Andrew Crockett Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Andrew Crockett. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Thomas Andrew Crockett's mailing address is: Wiltshire X0 Sp4 0jq.